EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Radiation Effects on Normal Brain in Subjects With Recurrent Glioblastoma by Spectroscopic MRI

Abram Abdou iD, Sulaiman Sheriff, Kelly Rojas, Miah Nicholls, Eric A Mellon

NMR in Biomedicine · 2026-06 · 39 (6)

DOI: 10.1002/nbm.70303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NMR in Biomedicine, online erschienen am 05.05.2026. Verfasst von Abram Abdou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Miami, Coral Gables, Florida, USA. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Magnetic Resonance Imaging, Brain. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor in adults and almost always recurs. In recurrent GBM, conventional MRI has limited ability to detect microscopic tumor infiltration and distinguish progression from treatment‐related change. Spectroscopic MRI (sMRI) provides quantitative metabolic maps across much of the brain, including choline (Cho) and N‐acetylaspartate (NAA), a marker of healthy tissue. Because Cho/NAA is commonly used to define metabolically abnormal tissue, and prior radiation therapy (RT) can alter metabolite levels, we evaluated whether prior RT shifts baseline Cho/NAA in recurrent disease. We retrospectively studied 20 patients with recurrent GBM previously treated with maximal safe resection, RT, and temozolomide who underwent whole‐brain sMRI at recurrence. The median interval from RT completion to sMRI was 8.99 months. T1‐weighted images were co‐registered to sMRI in MIDAS and aligned with planning CT in MIM to generate radiation dose maps. MIDAS generated tissue‐water‐referenced Cho, NAA, and creatine (Cr) maps, and Cho/NAA was normalized to contralateral normal‐appearing white matter. Voxel‐wise linear regression was performed between prior radiation dose and metabolite values at recurrence. Higher prior dose was associated with reduced NAA (−0.26%/Gy, r 2 = 0.011, p < 0.001) and Cr (−0.18%/Gy, r 2 = 0.004, p < 0.001), while Cho changed minimally (−0.023%/Gy, r 2 = 0.001, p < 0.001). Accordingly, normalized Cho/NAA increased with dose, with a mean slope of 0.0018/Gy ( p < 0.001). A standard Cho/NAA threshold of 2 corresponded to a median of 2.39 (range, 1.91–2.72) in tissue previously receiving 60 Gy. These findings suggest prior RT modestly elevates baseline Cho/NAA, primarily through NAA reduction, and that dose‐corrected Cho/NAA maps may improve tumor delineation in recurrent GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsMagnetic Resonance ImagingBrainNeoplasm Recurrence, LocalHumansMaleFemaleMiddle AgedAdultCholineMagnetic Resonance SpectroscopyAspartic AcidAged

Substanzen

CholineN-acetylaspartateAspartic Acid

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University of Miami, Coral Gables, Florida, USA.
  • Henry Ford Health + Michigan State University Health Sciences, Detroit, Michigan, USA.
  • Department of Radiation Oncology, Henry Ford Health, Detroit, Michigan, USA.
  • Department of Radiology, College of Human Medicine, East Lansing, Michigan, USA.

ORCID-Profile: Abram Abdou

Förderung

  • NCI NIH HHS

Zitieren

APA

Abdou, A., Sheriff, S., Rojas, K., Nicholls, M., & Mellon, E. A. (2026). Radiation Effects on Normal Brain in Subjects With Recurrent Glioblastoma by Spectroscopic MRI. NMR in Biomedicine, 39(6). https://doi.org/10.1002/nbm.70303

Vancouver

Abdou A, Sheriff S, Rojas K, Nicholls M, Mellon EA. Radiation Effects on Normal Brain in Subjects With Recurrent Glioblastoma by Spectroscopic MRI. NMR in Biomedicine. 2026;39(6). doi:10.1002/nbm.70303

BibTeX
@article{Abdou2026,
  author = {Abdou, Abram and Sheriff, Sulaiman and Rojas, Kelly and Nicholls, Miah and Mellon, Eric A},
  title = {Radiation Effects on Normal Brain in Subjects With Recurrent Glioblastoma by Spectroscopic MRI},
  journal = {NMR in Biomedicine},
  year = {2026},
  volume = {39},
  number = {6},
  doi = {10.1002/nbm.70303}
}
Kostenlos starten →